Opgen Inc Watch

from 8-K 11 pages Employment Agreement

from 8-K 4 pages Re: Inducement Offer to Amend Common Stock Purchase Warrants

from 8-K 10 pages Director Agreement

from 8-K 11 pages Sgp Schnr:icler Gel'wft:1- Restrukturierung Konigstrabe 18 70173 S1:uttgart Per Mail: Oschacht@opgen.com Opgen Inc. 9717 Key West Avenue Suite 100 Rockville, MD 20850 Vereinigte Staaten Sgp Schneider Geiwitz Dr. Jur. Volker Von Danckelmann Rechtsanwalt T +49 71122 05 48-60 F +49 711 22 Os 48-699 Stuttgart@ SCHNEIDERGEIWITZ.DE Lnsolvenzverfahren Uber Das Vermogen Der Curetis Gmbh, Max-Eyth Strabe 42, 71088 Holzgerlingen Geschafts-Nr.: 14 in 1471/23 Hier: Oberlassung Angebot Abschluss Teilverzicht Unsere Vorgangsnummer 6650610/K Bitte Angeben 21.03.2024/Vd Vorgangsnummer: 6650610/K Bltte Angeben Sehr Geehrter Herr Schacht, Dear Mr. Schacht, Anbei Erhalten Sie Das Angebot Zum Enclosed You Will Find the Offer to Conclude Abschluss Einer Teilverzichtsvereinbarung. a Partial Waiver Agreement. I Am Bound by Lch Halte Mich an Das Angebot Bis Zum the Offer Until Monday, April 25, 2024, 4:00 Montag, 25.04.2024, 16:00 Uhr (Zeit P.M. (Berlin Time}. Furthermore, the Offer Berlin) Gebunden. Ferner Verliert Das Will Cease to Be Valid Before Expiry of the Angebot Vor Ablauf Der Vorgenannten Frist Aforementioned Period if You Are No Seine Gultlgkeit, Wenn Sie Nicht Mehr Longer an Authorized Representative of Vertretungsberechtigtes Organ Der Opgen Opgen Inc. Inc. Sind. Als Lnsolvenzverwalter Anlage: Vereinbarung Anteiliger Forderungsverzicht Vom 21.03.2024 Sgp Schneider Geiwit• & Partner - Wirtschaftfprufer Steuerberater Flechtsanwalte Partgmbb Bankverblndunc Sparkasse Ulm I !Ban De78 6305 0000 0000 0202 93 I Sic-Code Soladeslulm Sitz Der Geselschaft Ulm I Reglsterpricht Pr 7203s2 AG Ulm I Ust-Ldnr. De 205060978 I WWW.SCHNEIDERGEIWLTZ.DE Unterschriftenversion Sgp 21.03.2024_1740 Uhr_dokument • \Lereinbarung IV Danckelmann-Opgen Inc_ Vereinbarung Anteiuger Forderungsverzicht Opgen Inc. Curetis Gmbh

from 8-K 17 pages European Investment Bank and Opgen, Inc. Settlement Agreement in Relation to a Guarantee and Indemnity Agreement Dated 9 July 2020

from 8-K 73 pages Securities Purchase Agreement

from 8-K 3 pages February 7, 2024 to the Holder of February 2018, February 2021, March 2021, October 2021, October 2022, January 2023, and May 2023 Warrants to Purchase Common Stock Re: Amendment to Inducement Offer Letter Dear Holder

from 8-K 8 pages Consulting Agreement

from 8-K 8 pages Consulting Agreement

from 8-K 3 pages October 26, 2023 to the Holder of February 2018, February 2021, March 2021, October 2021, October 2022, January 2023, and May 2023 Re: Amendment to Inducement Offer Letter Dear Holder

from 8-K 9 pages October 12, 2023 to the Holder of February 2018, February 2021, March 2021, October 2021, October 2022, January 2023, and May 2023 Re: Inducement Offer to Exercise Existing Common Stock Purchase Warrants Dear Holder

from 8-K 13 pages Preferred Stock Purchase Agreement

from 8-K 14 pages Execution Version Curetis Gmbh as Borrower Certain Companies as Guarantors and European Investment Bank as Bank Standstill Agreement Contents

from 8-K 2 pages Holder of Warrants to Purchase Common Stock Issued on January 11, 2023, October 3, 2022, October 18, 2021, March 9, 2021, February 9, 2021, February 2, 2018 Re: Amendment to Existing Warrants Dear Holder: Reference Is Hereby Made to the Offering on Form S-1 (File No. 333-271190) on or About the Date Hereof (The “Offering”) by Opgen, Inc. (The “Company”) of Its Common Stock, Par Value $0.01 Per Share (“Common Stock”), and/or Other Securities of the Company (Collectively, the “Securities”)

from 8-K 29 pages Securities Purchase Agreement

from S-1/A 34 pages Securities Purchase Agreement

from 10-K 1 page Non-Employee Director Compensation Policy

from S-1/A 26 pages Securities Purchase Agreement

from 8-K 2 pages Holder of Warrants to Purchase Common Stock Issued on October 18, 2021, March 9, 2021, February 9, 2021, February 2, 2018 Re: Amendment to Existing Warrants Dear Holder: Reference Is Hereby Made to the Offering on or About the Date Hereof (The “Offering”) by Opgen, Inc. (The “Company”) of Its Common Stock, Par Value $0.01 Per Share (“Common Stock”) (Collectively, the “Shares”)

from 8-K 32 pages Form of Securities Purchase Agreement